A106190 Stock Overview
Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for A106190 from our risk checks.
High Tech Pharm Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,620.00 |
| 52 Week High | ₩19,280.00 |
| 52 Week Low | ₩7,880.00 |
| Beta | 0.91 |
| 11 Month Change | -23.31% |
| 3 Month Change | -6.33% |
| 1 Year Change | 24.27% |
| 33 Year Change | 5.04% |
| 5 Year Change | 77.65% |
| Change since IPO | 48.04% |
Recent News & Updates
Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06
Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%
Jul 02There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Recent updates
Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%
Jul 02There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?
Jan 19What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?
Dec 15Shareholder Returns
| A106190 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -10.6% | -9.1% | -5.4% |
| 1Y | 24.3% | 8.5% | -3.8% |
Return vs Industry: A106190 exceeded the KR Pharmaceuticals industry which returned 8.5% over the past year.
Return vs Market: A106190 exceeded the KR Market which returned -3.8% over the past year.
Price Volatility
| A106190 volatility | |
|---|---|
| A106190 Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 6.8% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A106190's share price has been volatile over the past 3 months.
Volatility Over Time: A106190's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Jeong-Soo Kim | www.htpharm.com |
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
High Tech Pharm Co., Ltd. Fundamentals Summary
| A106190 fundamental statistics | |
|---|---|
| Market cap | ₩144.82b |
| Earnings (TTM) | ₩13.52b |
| Revenue (TTM) | ₩83.50b |
10.7x
P/E Ratio1.7x
P/S RatioIs A106190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A106190 income statement (TTM) | |
|---|---|
| Revenue | ₩83.50b |
| Cost of Revenue | ₩63.72b |
| Gross Profit | ₩19.78b |
| Other Expenses | ₩6.26b |
| Earnings | ₩13.52b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.27k |
| Gross Margin | 23.69% |
| Net Profit Margin | 16.19% |
| Debt/Equity Ratio | 14.9% |
How did A106190 perform over the long term?
See historical performance and comparison